Myanmar vs Niger: Access to anti-retroviral drugs, female
Myanmar
78.0%
in 2024
Niger
79.0%
in 2024
Myanmar rank
60th
Niger rank
59th
Access to anti-retroviral drugs, female over time
- Myanmar
- Niger
How they compare
Niger currently reports 79.0% against 78.0% in Myanmar, a difference of 1.0%.
Across all 25 years both countries report, Niger has been ahead every year.
Myanmar ranks 60th and Niger ranks 59th of 141 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.5% | 5.0% | 2.5% | Niger |
| 2010s | 39.2% | 54.5% | 15.3% | Niger |
| 2020s | 75.6% | 83.2% | 7.6% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Myanmar or Niger?
- Niger, at 79.0% against 78.0% in Myanmar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Myanmar and Niger?
- 1.0%, with Niger ahead.
- How many years of comparable data are there for Myanmar and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Myanmar and Niger rank globally for access to anti-retroviral drugs, female?
- Myanmar ranks 60th and Niger ranks 59th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.